Multiple myeloma specialist named first director of blood cancer center

February 06, 2022

1 minute read

We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

Faith E. Davies, MD, was named the first director of the Center for Blood Cancers at NYU Langone Health’s Perlmutter Cancer Center.

Davies is currently Director of the Myeloma Clinical Program at Perlmutter Cancer Center and Professor in the Department of Medicine at NYU Grossman School of Medicine.

She previously served as Medical Director of the University of Arkansas Myeloma Institute for Medical Sciences.

In her new role, she will work to enhance the Center for Blood Cancers’ clinical and translational research programs, recruit new investigators, and oversee the development of a biosample resource to facilitate cancer research. some blood.

Faith E. Davies, MD

Faith E. Davies

“We are delighted that Dr. Davies leads the Blood Cancer Center,” Michael L. Grossbard, MD, professor in the Department of Medicine at NYU Grossman School of Medicine and section chief of hematology at Perlmutter Cancer Center, said in a press release. “His work was fundamental in revealing the importance of achieving complete remission in the treatment of myeloma, and under his leadership the center is poised to expand treatment advances for all blood cancers.”

Davies and his colleagues are developing a portfolio of clinical trials focused on immunotherapy approaches. Studies are evaluating new immunomodulatory drugs, bispecific antibodies, and chimeric antigen receptor T cell therapies.

“I am thrilled to lead the Center for Blood Cancers,” Davies said. “The Perlmutter Cancer Center has an exceptional team of hematologists and medical oncologists, and I look forward to building on this strong foundation to provide improved care for our patients.

Comments are closed.